Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

Monday’s Trading Day
70.06 +1.04 / +1.51%
As of Aug 03
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
69.92 -0.14 / -0.20%
 
Volume: 1.0K

Today’s Trading

Previous close69.02
Today’s open69.06
Day’s range68.76 - 70.12
Volume5,149,710
Average volume (3 months)4,562,580
Market cap$66.3B
Dividend yield1.92%
Data as of 08/03/2015

Growth & Valuation

Earnings growth (last year)+139.61%
Earnings growth (this year)+4.03%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-0.47%
P/E ratio21.8
Price/Sales2.43
Price/Book2.52

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc0.000.00%
DNAIProNAi Therapeutics ...+1.14+4.16%
VBLTVascular Biogenics L...-0.26-4.33%
NEPTNeptune Technologies...0.000.00%
Data as of 08/03/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$1.30
Annual revenue (last year)$20.3B
Annual profit (last year)$3.1B
Net profit margin15.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts